Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms
Anna Falanga, Marina Marchetti, Francesca Schieppati · Zeitschrift für Orthopädie und Unfallchirurgie · 2021 · Heft 01 · S. 048-057
Bibliografische Angaben
Zusammenfassung
AbstractMyeloproliferative neoplasms (MPNs) are clonal disorders of the hematopoietic stem cell. Classical BCR/ABL-negative MPNs include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Thrombotic events are a major cause of morbidity and mortality in these patients. Pathogenesis of blood clotting activation involves various abnormalities of platelets, erythrocytes, and leukocytes, as well as dysfunctions of endothelial cells. Patients with MPN can be stratified in “high risk” or “low risk” of thrombosis according to established risk factors. ET and PV clinical management…
